Revelation Biosciences, Inc.
REVBW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810560
No open-market purchases or sales by Revelation Biosciences, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $9.99K in total; no superinvestor holds it.
Other share classesREVB
Q2 2025 vs. Q1 2025
How the institutions holding Revelation Biosciences, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 9 | 12 | +3 |
| Shares | 986.2K | 1.16M | +169.0K (+17.1%) |
| Value | $10.5K | $13.8K | +$3.27K (+31.0%) |
New holders (5)
Institutions that held Revelation Biosciences, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Clear Street LLC | 247,584 | $2.97K | 0.00% |
| Toronto Dominion Bank | 99,600 | $1.20K | 0.00% |
| Soltis Investment Advisors LLC | 47,500 | $570 | 0.00% |
| Susquehanna International Group, LLP | 33,468 | $402 | 0.00% |
| Quaker Wealth Management, LLC | 387 | $5 | 0.00% |
Sold out (2)
Institutions that held Revelation Biosciences, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Yakira Capital Management, Inc. | 246,884 | $2.68K |
| HRT Financial LP | 13,144 | $0 |